Silexion Therapeutics Corp (SLXN, SLXNW) (CIK 0002022416) CORRESP
A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.
Key facts
- Accession number
- 0001178913-25-003278
- Form
- CORRESP
- Filer
- Silexion Therapeutics Corp (SLXN, SLXNW) (CIK 0002022416)
- CIK
- 0002022416
- Ticker
- SLXN, SLXNW
- Filed
- 2025-09-09
- SIC industry
- 2836
- HQ
- Ramat Gan, L3
Primary source
PDF letter: https://www.sec.gov/Archives/edgar/data/2022416/000117891325003278/filename1.htm
EDGAR review index: browse all UPLOAD/CORRESP for this filer ↗
Other comment-letter activity for this filer